17.06.2008 Boehringer Ingelheim to acquire Actimis Pharmaceuticals 10.06.2008 New data shows pramipexole (Mirapexin®/Sifrol®) can significantly reduce limb pain in patients with Restless Legs Syndrome (RLS) For medical media, outside the US only 09.06.2008 Closure of the tipranavir POTENT trial 09.06.2008 Boehringer Ingelheim announces first positive health technology assessments for novel oral anticoagulant Pradaxa^® (dabigatran etexilate) For medical media, outside the US only 30.05.2008 Boehringer Ingelheim gets first approval within EU for Actilyse® 2mg to treat catheter dysfunction caused by thrombotic occlusion For medical media, outside the US only 14.05.2008 PRoFESS^® results announced at XVII European Stroke Conference For medical media, outside the US only 07.05.2008 Women suffering from Decreased Sexual Desire:
Silence hinders diagnosis of the prevalent condition Hypoactive Sexual Desire Disorder(HSDD) For medical media, outside the US only 28.04.2008 European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus^®) For medical media, outside the US only 25.04.2008 Data suggests promising overall survival and progression-free survival with Vargatef™ (BIBF 1120) For medical media, outside the US only 17.04.2008 New data confirm pramipexole (Mirapexin^®/Sifrol^®) can significantly reduce sleep disturbance for people with Restless Legs Syndrome (RLS) For medical media, outside the US only